Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., EVOQ Properties Inc., Fortegra Financial Corporation, I...

NEW YORK, Aug. 18, 2014 /PRNewswire/ --

Endocyte, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the Southern District of Indiana alleging that Endocyte, Inc. ("ECYT") issued false and misleading statements between March 21, 2014 and May 2, 2014.  Specifically, on May 2, 2014, Endocyte disclosed that VYNFINIT was found ineffective in the treatment of platinum-resistant ovarian cancer, based on certain testing methods known as response evaluation criteria in solid tumors, or "RECIST."

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

EVOQ Properties Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of EVOQ Properties Inc. ("EVOQ") to an entity established by affiliates of Atlas Capital Investors III, LLC, Square Mile Capital Management, LLC, and USAA Real Estate Company in a transaction valued at approximately $12.96 per share or $357.4 million.

Lifshitz & Miller's investigation is focused on whether the EVOQ directors are acting in shareholders best interest.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Fortegra Financial Corporation

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Fortegra Financial Corporation ("FRF") to Tiptree Financial Inc.  in a cash and stock transaction valued at approximately $10.00 per share or $218 million.

Lifshitz & Miller's investigation is focused on whether the FRF directors are acting in shareholders best interest.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

Intervest Bancshares Corporation

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed sale of Intervest Bancshares Corporation ("IBCA") to Bank of the Ozarks, Inc. in a stock transaction valued at approximately $228.5 million.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

L-3 Communications Holdings, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the Southern District of New York alleging that L-3 Communications Holdings, Inc. ("LLL") issued false and misleading statements between April 25, 2013 and July 30, 2014.  Specifically, the Complaint alleges that: (1) L-3's financial statements contained errors related to the improper deferral of cost overruns on a fixed-price maintenance and logistics support contract resulting in overstatement of operating income; (2) net sales with respect to the fixed-price maintenance and logistics support contract were overstated; and (3) the Company lacked adequate internal controls over financial reporting.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at [phone] or by sending an e-mail including your contact information to: [e-mail].

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: [phone].  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  [phone]
Facsimile: 516-280-7376
Email: [e-mail]

SOURCE Lifshitz & Miller Law Firm

Copyright 2014 PR Newswire